Found: 10
Select item for more details and to access through your institution.
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 18, p. N.PAG, doi. 10.3390/ijms231810222
- By:
- Publication type:
- Article
UMG1/CD3ε‐bispecific T‐cell engager redirects T‐cell cytotoxicity against diffuse large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 2, p. 555, doi. 10.1111/bjh.19183
- By:
- Publication type:
- Article
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1647, doi. 10.3390/cancers15061647
- By:
- Publication type:
- Article
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2886, doi. 10.3390/cancers14122886
- By:
- Publication type:
- Article
miR-22 Modulates Lenalidomide Activity by Counteracting MYC Addiction in Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4365, doi. 10.3390/cancers13174365
- By:
- Publication type:
- Article
miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1587, doi. 10.3390/cancers13071587
- By:
- Publication type:
- Article
Hit identification of novel small molecules interfering with MALAT1 triplex by a structure‐based virtual screening.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 8, p. 1, doi. 10.1002/ardp.202300134
- By:
- Publication type:
- Article
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02633-0
- By:
- Publication type:
- Article
The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-022-00368-w
- By:
- Publication type:
- Article